• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

茶碱的使用:综述

Theophylline use: an overview.

作者信息

Weinberger M, Hendeles L

出版信息

J Allergy Clin Immunol. 1985 Aug;76(2 Pt 2):277-84. doi: 10.1016/0091-6749(85)90642-6.

DOI:10.1016/0091-6749(85)90642-6
PMID:2862172
Abstract

Four critical issues related to theophylline are addressed: What is theophylline? Why use it? How should it be used? Who should receive it? Theophylline is a methylated xanthine with established clinical benefit as maintenance therapy for chronic asthma. In fact, evolution of our knowledge of the pharmacodynamics and pharmacokinetics of theophylline has made this drug the most effective nonsteroidal prophylactic used for chronic asthma. Theophylline has the potential for serious toxicity at excessive serum concentrations. Nonetheless, its major justification for use today, when so many other asthma medications have become available, is because of the high degree of efficacy that can be attained with appropriate use. The optimal likelihood of maximal safe effect is attained with maintenance of serum concentrations within the 10 to 20 micrograms/ml therapeutic range. Dosage should be individualized by clinical titration, guided by measurement of serum concentrations, and continued only if well tolerated; selection of appropriate products and dosing intervals permits maintenance of acceptably stable serum concentrations. Asthma in patients only intermittently symptomatic, regardless of severity, is probably best treated by intervention measures with inhaled bronchodilators, supplemented when necessary by short-term use of oral corticosteroids, rather than by long-term maintenance therapy. Theophylline therapy in patients with obstructive pulmonary disease other than asthma should generally be highly selective and based on clearly demonstrable clinical benefit.

摘要

本文讨论了与茶碱相关的四个关键问题

什么是茶碱?为什么使用它?应该如何使用?谁应该使用它?茶碱是一种甲基化黄嘌呤,作为慢性哮喘的维持治疗药物,具有确切的临床疗效。事实上,我们对茶碱药效学和药代动力学认识的发展,使这种药物成为用于慢性哮喘最有效的非甾体类预防性药物。当血清浓度过高时,茶碱有产生严重毒性的可能。尽管如此,在如今有如此多其他哮喘药物可供使用的情况下,它目前使用的主要理由是,合理使用时可获得高度的疗效。通过将血清浓度维持在10至20微克/毫升的治疗范围内,可实现最大安全效果的最佳可能性。剂量应通过临床滴定个体化,以血清浓度测量为指导,只有在耐受性良好的情况下才继续用药;选择合适的产品和给药间隔可维持可接受的稳定血清浓度。对于仅有间歇性症状的哮喘患者,无论严重程度如何,可能最好通过吸入支气管扩张剂进行干预治疗,必要时辅以短期口服糖皮质激素,而非长期维持治疗。对于哮喘以外的阻塞性肺疾病患者,茶碱治疗通常应具有高度选择性,并基于明确可证的临床益处。

相似文献

1
Theophylline use: an overview.茶碱的使用:综述
J Allergy Clin Immunol. 1985 Aug;76(2 Pt 2):277-84. doi: 10.1016/0091-6749(85)90642-6.
2
American Academy of Pediatrics. Section on Allergy and Immunology. Management of asthma.美国儿科学会。过敏与免疫学分会。哮喘管理
Pediatrics. 1981 Dec;68(6):874-9.
3
Experience with theophylline for the management of chronic asthma.茶碱用于慢性哮喘管理的经验。
Eur J Respir Dis Suppl. 1980;109:120-33.
4
Theophylline for chronic asthma: rationale for treatment, product selection, and dosage schedule.用于慢性哮喘的茶碱:治疗原理、产品选择及给药方案
Pediatr Pharmacol (New York). 1983;3(3-4):273-85.
5
Nocturnal asthma uncontrolled by inhaled corticosteroids: theophylline or long-acting beta2 agonists?吸入性糖皮质激素无法控制的夜间哮喘:茶碱还是长效β2受体激动剂?
Drugs. 2001;61(3):391-418. doi: 10.2165/00003495-200161030-00007.
6
Pharmacologic management of asthma.哮喘的药物治疗
J Adolesc Health Care. 1987 Jan;8(1):74-83. doi: 10.1016/0197-0070(87)90248-8.
7
Management of asthma. 2. Antiasthmatic drugs.
Postgrad Med. 1977 May;61(5):95-100, 103. doi: 10.1080/00325481.1977.11712185.
8
Theophylline for treatment of asthma.用于治疗哮喘的茶碱。
J Pediatr. 1978 Jan;92(1):1-7. doi: 10.1016/s0022-3476(78)80058-4.
9
Therapeutic effect and dosing strategies for theophylline in the treatment of chronic asthma.
J Allergy Clin Immunol. 1986 Oct;78(4 Pt 2):762-8. doi: 10.1016/0091-6749(86)90058-8.
10
Asthma in the 1990s. A new approach to therapy.20世纪90年代的哮喘。一种新的治疗方法。
Postgrad Med. 1992 Nov 1;92(6):177-8, 183-6, 189-90. doi: 10.1080/00325481.1992.11701519.